Provided by Tiger Trade Technology Pte. Ltd.

Amgen

439.33
+8.121.88%
Post-market: 439.05-0.2800-0.06%19:56 EDT
Volume:2.11M
Turnover:926.13M
Market Cap:236.57B
PE:27.29
High:440.51
Open:431.72
Low:429.38
Close:431.21
52wk High:443.20
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.82
T/O Rate:0.39%
Dividend:9.80
Dividend Rate:2.23%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.24
PE(LYR):30.87

Loading ...

Movement Alert|Amgen Rises 4.2% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Raised Full-Year Guidance

Market Focus
·
Aug 05

Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366

THOMSON REUTERS
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Morgan Stanley Adjusts Price Target on Amgen to $351 From $333, Maintains Equalweight Rating

MT Newswires Live
·
Aug 05

Amgen Inc : Scotiabank Raises Target Price to $450 from $385

THOMSON REUTERS
·
Aug 05

Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong

Dow Jones
·
Aug 05

Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting

Reuters
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333

THOMSON REUTERS
·
Aug 05

Amgen Inc : Oppenheimer Raises Target Price to $450 from $400

THOMSON REUTERS
·
Aug 05

TD Cowen Sticks to Its Buy Rating for Amgen (AMGN)

TIPRANKS
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Amgen Announces Availability of Q2 2026 Earnings Report Release

Reuters
·
Aug 05

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Deep News
·
Aug 05

Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch

THOMSON REUTERS
·
Aug 05

Amgen Exec Says Expect a Meaningful Sequential Increase in Operating Expenses in the Third Quarter

THOMSON REUTERS
·
Aug 05

Amgen Exec Says Spent $500 Million in Q2 on Capital Expenditures, Driven by Investments Across United States Manufacturing Sites-Conf Call

THOMSON REUTERS
·
Aug 05

Amgen Q2 FY26 GAAP EPS Rises 65% to $4.37; Revenue Increases 10% to $10.1 Billion

Reuters
·
Aug 05